Jatara McGee, WLWT |
Dr. Robert Frenk, who leads the research for Pfizer’s vaccines at Children’s Hospital, said the trials will begin in Cincinnati Monday with a group of eight children, ages 5 to 11.
“We’ve had about 300 or 400 families that have contacted us at least showing preliminary interest,” Frenk said.
The children will receive the same vaccine that millions of adults have already received. The trials will begin by giving the children a smaller dose. Each child will receive a vaccine. No one will receive dummy shots.
Pfizer said the global study involves 144 participants and will examine if the vaccine can generate an immune response in kids. It will also determine the proper dosage for the age groups in trial: 6 months to 2 years, 2 years to 5 years and 5 years to 11 years.